Oct 24, 2024 · AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives

AbbVie has been accused of using anti-competitive patent thickets to prevent potentially cheaper biosimilars from entering the market. AbbVie and Alvotech, filed lawsuits against each other …

Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing.

When we became our own company, AbbVie formed a new kind of enterprise—a biopharmaceutical company. We blend the stability, global scale, resources and commercial …

Dec 27, 2025 · So, AbbVie has robust underlying operations, a strong outlook through the next decade, is reasonably valued, and offers an exceptional dividend program. The stock is a …

3 days ago · AbbVie has delivered strong YTD outperformance, with shares up nearly 30% and robust analyst optimism, but I maintain a 'Hold' rating.

Oct 24, 2024 · At AbbVie, our people are dedicated to putting patients at the center of everything we do. Every breakthrough, every innovation, and every step forward is inspired by the real …

About us AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world.

1 day ago · AbbVie (ABBV) has been drawing fresh attention after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months as investors …

When we became our own company, AbbVie formed a new kind of enterprise—a biopharmaceutical company. We blend the stability, global scale, resources and commercial …